Download the PDF version

Online Availability of Sanofi Group's Half-Year Financial Report for 2015

Paris, France - July 31, 2015 - Sanofi (EURONEXT : SAN ; NYSE : SNY) announces that its half-year financial report for the period ending June 30, 2015 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K.

This document may be found on the company's corporate website: and down loaded from the "Investors" page under the heading "Regulated Information in France."

About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).


Media Relations Investor Relations
Laurence Bollack Sébastien Martel
Tel.:+33 (0) 1 53 77 46 46 Tel.: +33 (0) 1 53 77 45 45